Zhigang C. Wang

7.4k citations

22 papers · 3.9k indexed · 3 hit papers · h-index 16

Cancer Research top 1%
- Cancer Genomics and Diagnostics 6
Oncology top 1%
- PARP inhibition in cancer therapy 4
Molecular Biology top 2%
- DNA Repair Mechanisms 5
- Gene expression and cancer classification 3
- Genomics and Chromatin Dynamics 3
- Molecular Biology Techniques and Applications 2
Reproductive Medicine top 5%
Genetics top 5%
- BRCA gene mutations in cancer 6
- Genomic variations and chromosomal abnormalities 4

Co-authors: J. Dirk Iglehart Andrea L. Richardson Alexander Miron Xin Lü Arcangela De Nicolo Myles Brown Shridar Ganesan David M. Livingston
Cited by: Cancer Research Oncology Molecular Biology
Journals: Cell (1 paper)Proceedings of the National Academy of Sciences (1 paper)Nature Medicine (1 paper)
Partner nations: United States Denmark United Kingdom

In The Last Decade

Zhigang C. Wang

21 papers receiving 3.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Zhigang C. Wang

Since Specialization

Citations

This map shows the geographic impact of Zhigang C. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhigang C. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhigang C. Wang more than expected).

Fields of papers citing papers by Zhigang C. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhigang C. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhigang C. Wang. The network helps show where Zhigang C. Wang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Zhigang C. Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zhigang C. Wang Line = papers co-authored together Zhigang C. Wang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition Clinical Cancer Research ·Kalindi Parmar,Bose Kochupurakkal,Jean‐Bernard Lazaro,Zhigang C. Wang,Sangeetha Palakurthi,Paul T. Kirschmeier,Chunyu Yang,Larissa A. Sambel,Anniina Färkkilä,Elizaveta Reznichenko,Hunter D. Reavis,Connor E. Dunn,Lee Zou,T. Khanh,Panagiotis A. Konstantinopoulos,Ursula A. Matulonis,Joyce F. Liu,Alan D. D’Andrea,Geoffrey I. Shapiro	2019	103
2	RelA-Induced Interferon Response Negatively Regulates Proliferation PLoS ONE ·Bose Kochupurakkal,Zhigang C. Wang,Tony Hua,Aedín C. Culhane,Scott J. Rodig,Koraljka Rajković Molek,Jean-Bernard Lazaro,Andrea L. Richardson,Debajit K. Biswas,J. Dirk Iglehart	2015	18
3	CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancerbreakdown → Cell ·Yubao Wang,Tinghu Zhang,Nicholas Kwiatkowski,Brian J. Abraham,Tong Ihn Lee,Shaozhen Xie,Haluk Yuzugullu,Thanh Von,Heyuan Li,Ziao Lin,Daniel G. Stover,Elgene Lim,Zhigang C. Wang,J. Dirk Iglehart,Richard A. Young,Nathanael S. Gray,Jean J. Zhao	2015	347
4	Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs Biomarker Research ·Andrea Marion Marquard,Aron C. Eklund,Tejal Joshi,Marcin Krzystanek,Francesco Favero,Zhigang C. Wang,Andrea L. Richardson,Daniel P. Silver,Zoltán Szállási,Nicolai J. Birkbak	2015	180
5	Tumor Mutation Burden Forecasts Outcome in Ovarian Cancer with BRCA1 or BRCA2 Mutations PLoS ONE ·Nicolai J. Birkbak,Bose Kochupurakkal,José M. G. Izarzugaza,Aron C. Eklund,Yang Li,Joyce F. Liu,Zoltán Szállási,Ursula A. Matulonis,Andrea L. Richardson,J. Dirk Iglehart,Zhigang C. Wang	2013	105
6	Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents Cancer Discovery ·Nicolai J. Birkbak,Zhigang C. Wang,Ji-Young Kim,Aron C. Eklund,Qiyuan Li,Ruiyang Tian,Christian Bowman-Colin,Yang Li,April Greene-Colozzi,J. Dirk Iglehart,Nadine Tung,Paula D. Ryan,Judy E. Garber,Daniel P. Silver,Zoltán Szállási,Andrea L. Richardson	2012	412
7	The p110α and p110β isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis Genes & Development ·Tamara Utermark,Trisha Rao,Hailing Cheng,Qi Wang,Sang‐Hyun Lee,Zhigang C. Wang,J. Dirk Iglehart,Thomas M. Roberts,William J. Muller,Jean J. Zhao	2012	112
8	Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblastsbreakdown → Proceedings of the National Academy of Sciences ·Yasushi Kojima,Ahmet Acar,Elinor Ng Eaton,Kieran T. Mellody,Christina Scheel,Ittai Ben‐Porath,Tamer T. Önder,Zhigang C. Wang,Andrea L. Richardson,Robert A. Weinberg,Akira Orimo	2010	659
9	High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays SHILAP Revista de lepidopterología ·(unknown),(unknown),(unknown),(unknown),Li Zhang,Martin Moorhead,Zhigang C. Wang,(unknown),(unknown),(unknown),(unknown),Aysegul Sahin,Ralf Krahe,Musaffe Tuna,Patricia A. Thompson,Paul T. Spellman,Joe W. Gray,Gordon B. Mills,Malek Faham	2009	79
10	Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K Signaling Cancer Cell ·Christina Gewinner,Zhigang C. Wang,Andrea L. Richardson,Julie Teruya‐Feldstein,Dariush Etemadmoghadam,David D.L. Bowtell,Jordi Barretina,William M. Lin,Lucia E. Rameh,Leonardo Salmena,Pier Paolo Pandolfi,Lewis C. Cantley	2009	365
11	SIK1 Couples LKB1 to p53-Dependent Anoikis and Suppresses Metastasis Science Signaling ·Hailing Cheng,Pixu Liu,Zhigang C. Wang,Lihua Zou,Stephanie Santiago,Victoria M. Garbitt,Ole Gjoerup,J. Dirk Iglehart,Alexander Miron,Andrea L. Richardson,William C. Hahn,Jean J. Zhao	2009	131
12	Predicting features of breast cancer with gene expression patterns Breast Cancer Research and Treatment ·Xuesong Lu,Xin Lü,Zhigang C. Wang,J. Dirk Iglehart,Xuegong Zhang,Andrea L. Richardson	2007	188
13	Amplification of chromosome 8q22 and metastasis of breast cancers Cancer Research ·Zhigang C. Wang,Yan Li,J. Dirk Iglehart,Andrea L. Richardson	2006	2
14	X chromosomal abnormalities in basal-like human breast cancerbreakdown → Cancer Cell ·Andrea L. Richardson,Zhigang C. Wang,Arcangela De Nicolo,Xin Lü,Myles Brown,Alexander Miron,Xiaodong Liao,J. Dirk Iglehart,David M. Livingston,Shridar Ganesan	2006	668
15	A role for the scaffolding adapter GAB2 in breast cancer Nature Medicine ·Mohamed Bentires‐Alj,Susana G. Gil,Richard Chan,Zhigang C. Wang,Yongping Wang,Naoko Imanaka,Lyndsay N. Harris,Andrea L. Richardson,Benjamin G. Neel,Haihua Gu	2005	159
16	Maternal CD46H2 and IL1B-5111 homozygosity in T helper 1-type immunity to trophoblast antigens in recurrent pregnancy loss Human Reproduction ·Zhigang C. Wang,Joseph A. Hill,Edmond J. Yunis,Ling Xiao,Deborah J. Anderson	2005	15
17	BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles Breast Cancer Research and Treatment ·Evan Matros,Zhigang C. Wang,Gabriela Lodeiro,Alexander Miron,J. Dirk Iglehart,Andrea L. Richardson	2005	143
18	Genomic approaches in cancer biology Surgery ·Evan Matros,Zhigang C. Wang,Andrea L. Richardson,J. Dirk Iglehart	2004	2
19	Loss of Heterozygosity and Its Correlation with Expression Profiles in Subclasses of Invasive Breast Cancers Cancer Research ·Zhigang C. Wang,Ming Gang Lin,L. J. Wei,Cheng Li,Alexander Miron,Gabriella Lodeiro,Lyndsay Harris,Sridhar Ramaswamy,David M. Tanenbaum,Matthew Meyerson,J. Dirk Iglehart,Andrea Richardson	2004	150
20	Molecular characterization of the HLA-Cw∗0409N allele Human Immunology ·Zhigang C. Wang,Anajane G. Smith,Edmond J. Yunis,Annamalai Selvakumar,Soldano Ferrone,Susan McKinney,Jar-How Lee,Marcelo Fernández-Viña,John A. Hansen	2002	11

About Zhigang C. Wang

Zhigang C. Wang is a scholar working on Cancer Research, Oncology and Genetics, having authored 22 papers that have together received 3.9k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (6 papers), Cancer Genomics and Diagnostics (6 papers), DNA Repair Mechanisms (5 papers), Genomic variations and chromosomal abnormalities (4 papers), PARP inhibition in cancer therapy (4 papers), Gene expression and cancer classification (3 papers), Genomics and Chromatin Dynamics (3 papers) and Molecular Biology Techniques and Applications (2 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.9k citations) and Molecular Biology (2.6k citations). Zhigang C. Wang has collaborated with scholars based in United States, Denmark and United Kingdom. Frequent co-authors include J. Dirk Iglehart, Andrea L. Richardson, Andrea L. Richardson, Alexander Miron, Xin Lü, Arcangela De Nicolo, Myles Brown, Shridar Ganesan, David M. Livingston and Xiaodong Liao. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact